UGCG and B-cell chronic lymphocytic leukemia: These findings emphasize the critical role of UGCG and GluCer metabolism in CLL pathogenesis, which was corroborated by the pro-proliferative effect of C16:0 GluCer in leukemic cell models [5, 13].